StockData
Myriad Genetics Inc logo

Myriad Genetics Inc (MYGN) stock

MYGNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3070% below fair value
$5.53−0.01 (-0.18%)

Close on Nov 18, 2026Market cap $528.94MP/E –Yield –

Myriad Genetics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Myriad Genetics's market cap was $546.83M on Nov 11, 2026, against $710.35M a year earlier. Over the last 5 years it ranged from $269.98M to $2.58B, with a median of $1.53B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$546.83M-4.5%
2025Dec 31, 2025$572.57M-54.1%
2024Dec 31, 2024$1.25B-20.6%
2023Dec 29, 2023$1.57B+33.9%
2022Dec 30, 2022$1.17B-43.1%
2021Dec 31, 2021$2.06B+39.6%
2020Dec 31, 2020$1.48B-27.1%
2019Dec 31, 2019$2.03B-6.7%
2018Dec 31, 2018$2.17B-8.6%
2017Dec 29, 2017$2.38B+108.4%
2016Dec 30, 2016$1.14B-61.9%
2015Dec 31, 2015$3.00B+20.5%
2014Dec 31, 2014$2.49B+54.3%
2013Dec 31, 2013$1.61B-27.3%
2012Dec 31, 2012$2.22B+25.2%
2011Dec 30, 2011$1.77B-16.0%
2010Dec 31, 2010$2.11B-18.0%
2009Dec 31, 2009$2.57B–

More Myriad Genetics figures

See a number that looks wrong?